Barclays Maintains an 'Overweight' on Oracle (ORCL); Expecting In-line Q4 as Risks Are Balanced

June 11, 2012 2:34 PM EDT Send to a Friend
Get Alerts ORCL Hot Sheet
Price: $34.09 -0.9%

Rating Summary:
    18 Buy, 10 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 12 | Down: 19 | New: 22
Trade ORCL Now!
Barclays maintains an 'Overweight' on Oracle (NASDAQ: ORCL) price target of $37.00.

Analyst, Raimo Lenschow, said, "In our view, numbers are likely to be in line. On the one hand, Q4 consensus is well below normal seasonality, while Q1 FY13 consensus appears to be seasonally normal. However, there are good reasons to be cautious. 1) Q4 and Q1 comparables are relatively tough; 2) macroeconomic data have been uninspiring; 3) recent USD strength presents a FX headwind; and 4) sentiment at the end of May was particularly negative."

Barclays slightly lowers FY12 EPS estimate from $2.42 to $2.40 and FY13 from $2.69 to $2.67.

For an analyst ratings summary and ratings history on Oracle click here. For more ratings news on Oracle click here.

Shares of Oracle closed at $27.16 yesterday, with a 52 week range of $24.72-$34.13.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View

Related Entities

Barclays

Add Your Comment